These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES. CLIFFTON EE; AGOSTINO D J Natl Cancer Inst; 1964 Nov; 33():753-63. PubMed ID: 14231149 [No Abstract] [Full Text] [Related]
5. ACUTE FIBRINOLYTIC STATES IN SURGERY. MCNICOL GP; DOUGLAS AS Proc R Soc Med; 1965 Apr; 58(4):259-61. PubMed ID: 14263735 [No Abstract] [Full Text] [Related]
6. [PRESENT TRENDS IN THE THERAPY OF HYPERFIBRINOLYTIC STATES]. DETTORI AG; PONARI O Clin Ter; 1963 Oct; 27():97-114. PubMed ID: 14100829 [No Abstract] [Full Text] [Related]
7. THE STABILITY OF FIBRINOLYTIC INHIBITORS IN HUMAN SERUM AND THE INHIBITOR CONTENT IN ANIMAL SERA. BLIX S Scand J Clin Lab Invest; 1964; 16():614-6. PubMed ID: 14224486 [No Abstract] [Full Text] [Related]
8. AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS. SWEENEY WM Am J Med Sci; 1965 May; 249():576-89. PubMed ID: 14283294 [No Abstract] [Full Text] [Related]
9. [THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS]. MARKWARDT F; KLOECKING HP; RICHTER M Acta Biol Med Ger; 1964; 12():522-4. PubMed ID: 14134957 [No Abstract] [Full Text] [Related]
10. [ON THE THERAPEUTIC USE OF EPSILON-AMINOCAPROIC ACID AND OTHER ANTIFIBRINOLYTICS]. PERLICK E Dtsch Gesundheitsw; 1964 May; 19():900-3. PubMed ID: 14220146 [No Abstract] [Full Text] [Related]
11. [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. I. SPECIFIC INHIBITORS OF FIBRINOLYSIS]. NIEWIAROWSKI S Pol Arch Med Wewn; 1964; 34():211-7. PubMed ID: 14151493 [No Abstract] [Full Text] [Related]
12. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS. MCNICOL GP; DOUGLAS AS Br Med Bull; 1964 Sep; 20():233-9. PubMed ID: 14209764 [No Abstract] [Full Text] [Related]
13. [OBSTETRICAL HEMORRHAGIC SYNDROMES. OBSERVATIONS AND CONSIDERATIONS OF A PHYSIOPATHOLOGICAL, CLINICAL AND THERAPEUTIC NATURE]. MARZETTI L; MORINI A Minerva Ginecol; 1964 Feb; 16():95-106. PubMed ID: 14137002 [No Abstract] [Full Text] [Related]
14. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR. NANNINGA LB; GUEST MM Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698 [No Abstract] [Full Text] [Related]
15. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS. TICE DA; WORTH MH; CLAUSS RH; REED GH Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354 [No Abstract] [Full Text] [Related]
16. [EXPERIMENT WITH A PLASMIN PREPARATION BY USING THE CASIN SPLITTING TEST: THE ACTION OF PLASMIN-NOVO AND ITS INHIBITION WITH EPSILON-AMINOCAPROIC ACID AND TRASYLOL]. BERGHOFF A; GLATZEL H Thromb Diath Haemorrh; 1964 Dec; 12():418-24. PubMed ID: 14254701 [No Abstract] [Full Text] [Related]
18. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS. KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647 [No Abstract] [Full Text] [Related]
19. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR. BECK E; SCHMUTZLER R; DUCKERT F Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273 [No Abstract] [Full Text] [Related]
20. FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES. EISEN V Br Med Bull; 1964 Sep; 20():205-9. PubMed ID: 14209760 [No Abstract] [Full Text] [Related] [Next] [New Search]